search
Back to results

Airway Collapse in Patients With Mounier-Kuhn Syndrome: Titration With Positive Pressure to Reduce Collapse

Primary Purpose

Mounier-Kuhn Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Non invasive ventilation - Continuous Positive Airway Pressure
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Mounier-Kuhn Syndrome focused on measuring Tracheal, Bronchial, Tracheobronchiomegaly, Collapse, obstructive sleep apnea syndrome, Computer Tomography, Impedance Tomography

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Has Mounier-Khun Syndrome
  • Accept and signed informed consent form

Exclusion Criteria:

  • Other morbidity avoiding study procedures

Sites / Locations

  • Divisao de Pneumologia, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao PauloRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

MKS pax

Arm Description

Munier-Kuhn Syndrome patients

Outcomes

Primary Outcome Measures

Percentage of tracheal-bronchial collapse area before and after applied positive pressure through bronchoscopy
Identify the prevalence of collapse and whether it is possible to counteract an optimum pressure generated by NIV with CPAP that reduces tracheal and bronchial collapse in patients with SMK

Secondary Outcome Measures

Apnea+hypopnea (AHI) index in patients with SMK
Study the frequency of OSAHS in patients with SMK;
Percentage of tracheal-bronchial collapse area before and after applied positive pressure measure using chest tomography
Record reversal of collapse with CPAP using chest tomography
Inspiratory and expiratory lung volumes before and after applied positive pressure measure using electrical impedance tomography.
To identify the impact of CPAP on the distribution of pulmonary ventilation through the analysis of electrical impedance tomography.

Full Information

First Posted
March 23, 2017
Last Updated
October 24, 2017
Sponsor
University of Sao Paulo General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03101059
Brief Title
Airway Collapse in Patients With Mounier-Kuhn Syndrome: Titration With Positive Pressure to Reduce Collapse
Official Title
Evaluation of the Presence of Airway Collapse in Patients With Mounier-Kuhn Syndrome and Titration With Continuous Positive Pressure Through Non-invasive Mechanical Ventilation to Reduce Collapse
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Unknown status
Study Start Date
June 8, 2017 (Actual)
Primary Completion Date
September 2018 (Anticipated)
Study Completion Date
April 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Mounier-Kuhn syndrome (MKS), or congenital tracheobronchiomegaly, is an entity characterized by dilation of the trachea and bronchi, associated with respiratory infections.The main signs and symptoms are cough, bulging and purulent expectoration, digital clubbing, dyspnoea, and wheezing.Some of these symptoms are believed to be due to excessive collapse of the intra-thoracic trachea and bronchi, resulting in airways obstruction of more than 50% . The purpose of this study is to identify and reduce tracheal collapse.
Detailed Description
Mounier-Kuhn syndrome (MKS), or congenital tracheobronchiomegaly, is an entity characterized by dilation of the trachea and bronchi, associated with respiratory infections. The prevalence among patients with respiratory symptoms is 0.4 to 1.6%. Its histological features include the atrophy or absence of longitudinal elastic fibers and smooth muscle cells of the airways, responsible for the structural alterations found, such as tracheobronchiomegaly, the presence of inter cartilaginous diverticula, bulging and dilation of the walls of the trachea and bronchi. The main signs and symptoms are cough, bulging and purulent expectoration, digital clubbing, dyspnoea, and wheezing and wheezing accompanied by recurrent respiratory infection. There may be association with other comorbidities such as gastroesophageal reflux disease, chronic obstructive pulmonary disease, bronchiectasis and obstructive sleep apnea / hypopnea syndrome (OSAS). Some of these symptoms are believed to be due to the tracheobronchial disease present in some patients, defined by excessive collapse of the intrathoracic trachea and bronchi resulting in airways obstruction of more than 50%. The main clinical impact is obstruction to expiratory airflow, with consequent air entrapment, reduction of cough and bronchial hygiene effectiveness, facilitating recurrent respiratory infections. Because it is a rare morbidity and little studied, the specific therapy is not consensual, and the main interventions are extrapolated from other pathologies. The use of non invasive mechanical ventilation (NIMV) with continuous positive airway pressure (CPAP) is reported as an option for treatment, however, there are no randomized studies proving its efficacy. The purpose of this study is to identify and reduce tracheal collapse and bronchi of SMK carriers with the use of positive pressure (CPAP-NIV) and to analyse their repercussion in the small airways.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mounier-Kuhn Syndrome
Keywords
Tracheal, Bronchial, Tracheobronchiomegaly, Collapse, obstructive sleep apnea syndrome, Computer Tomography, Impedance Tomography

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MKS pax
Arm Type
Experimental
Arm Description
Munier-Kuhn Syndrome patients
Intervention Type
Procedure
Intervention Name(s)
Non invasive ventilation - Continuous Positive Airway Pressure
Intervention Description
To identify, through bronchoscopy, the prevalence of collapse and whether it is possible to counteract an optimum pressure generated by NIV with CPAP that reduces tracheal and bronchial collapse in patients with SMK; To study the frequency of OSAS in patients with MKS ; Record reversal of collapse with CPAP using chest tomography; To identify the impact of CPAP on the distribution of pulmonary ventilation through the analysis of electrical impedance tomography.
Primary Outcome Measure Information:
Title
Percentage of tracheal-bronchial collapse area before and after applied positive pressure through bronchoscopy
Description
Identify the prevalence of collapse and whether it is possible to counteract an optimum pressure generated by NIV with CPAP that reduces tracheal and bronchial collapse in patients with SMK
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Apnea+hypopnea (AHI) index in patients with SMK
Description
Study the frequency of OSAHS in patients with SMK;
Time Frame
24 months
Title
Percentage of tracheal-bronchial collapse area before and after applied positive pressure measure using chest tomography
Description
Record reversal of collapse with CPAP using chest tomography
Time Frame
24 months
Title
Inspiratory and expiratory lung volumes before and after applied positive pressure measure using electrical impedance tomography.
Description
To identify the impact of CPAP on the distribution of pulmonary ventilation through the analysis of electrical impedance tomography.
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Has Mounier-Khun Syndrome Accept and signed informed consent form Exclusion Criteria: Other morbidity avoiding study procedures
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rafael Stelmach, MD-PHD
Phone
551126615191
Email
rafael.stelmach@incor.usp.br
First Name & Middle Initial & Last Name or Official Title & Degree
Evelise Lima, MD
Phone
551126615191
Email
eveliselima53@gmail.com
Facility Information:
Facility Name
Divisao de Pneumologia, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo
City
Sao Paulo
ZIP/Postal Code
05403000
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rafael Stelmach, MD-PHD
Phone
551126615191
Email
rafael.stelmach@incor.usp.br
First Name & Middle Initial & Last Name & Degree
Evelise Lima, MD
Phone
551126615191
Email
eveliselima53@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32795996
Citation
Lima E, Nakamura MAM, Genta PR, Rodrigues AJ, Athanazio RA, Rached S, Costa ELV, Stelmach R. Improving Airways Patency and Ventilation Through Optimal Positive Pressure Identified by Noninvasive Mechanical Ventilation Titration in Mounier-Kuhn Syndrome: Protocol for an Interventional, Open-Label, Single-Arm Clinical Trial. JMIR Res Protoc. 2020 Aug 14;9(8):e14786. doi: 10.2196/14786.
Results Reference
derived

Learn more about this trial

Airway Collapse in Patients With Mounier-Kuhn Syndrome: Titration With Positive Pressure to Reduce Collapse

We'll reach out to this number within 24 hrs